Early cancer drug study focuses on how genetics affect medication processing
Knowledge-focused
Completed
This early-phase study examined how the cancer drug belinostat is processed by the body in patients with advanced solid tumors or blood cancers that have returned or stopped responding to treatment. Researchers specifically looked at how different genetic variations affect drug p…
Phase: PHASE1 • Sponsor: Acrotech Biopharma Inc. • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:14 UTC